MARKER THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 1066395, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | MARKER THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:54:33.612027+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/554f7eb3-eb7d-4ee7-a772-1bf72173503c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-26-031274Retrieved: 2026-08-19T10:54:33.612027+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001094038/accounts-payable/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/554f7eb3-eb7d-4ee7-a772-1bf72173503c
History
- supersedes {"amount": 1066000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001410578-25-000549)